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In Brief
Previous studies have shown a
connection between energy metabolism
and pluripotency in human embryonic
stem cells. Marsboom et al. provide a
molecular explanation for this
observation and argue that the
pluripotency regulator OCT4 is a redox-
based metabolic sensor that undergoes
oxidation and degradation during
glutamine withdrawal.
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The molecular mechanisms underlying the regula-
tion of pluripotency by cellular metabolism in human
embryonic stem cells (hESCs) are not fully under-
stood. We found that high levels of glutamine meta-
bolism are essential to prevent degradation of
OCT4, a key transcription factor regulating hESC
pluripotency. Glutamine withdrawal depletes the
endogenous antioxidant glutathione (GSH), which
results in the oxidation of OCT4 cysteine residues
required for its DNA binding and enhanced OCT4
degradation. The emergence of the OCT4lo cell pop-
ulation following glutamine withdrawal did not result
in greater propensity for cell death. Instead, gluta-
mine withdrawal during vascular differentiation of
hESCs generated cells with greater angiogenic ca-
pacity, thus indicating that modulating glutamine
metabolism enhances the differentiation and func-
tional maturation of cells. These findings demon-
strate that the pluripotency transcription factor
OCT4 can serve as a metabolic-redox sensor in
hESCs and that metabolic cues can act in concert
with growth factor signaling to orchestrate stem
cell differentiation.INTRODUCTION
Human embryonic stem cells (hESCs) derived from the inner
cell mass of the blastocyst give rise to cells from three germ
layers when exposed to specific differentiation cues (Thomson
et al., 1998). Energy metabolism in hESCs depends largely on
cytosolic glycolysis (Turner et al., 2014), resembling the War-
burg effect observed in cancer cells (Hsu and Sabatini, 2008).
Evidence for the intertwined nature of pluripotency and meta-
bolism comes from the observation that dedifferentiation of
somatic cells into induced pluripotent stem cells (iPSCs) isThis is an open access article undaccompanied by changes in energy metabolism that are both
crucial and precede the induction of pluripotency (Folmes
et al., 2011). hESCs also have low levels of reactive oxygen
species (ROS), which is important to maintain pluripotency
(Cho et al., 2006; Ji et al., 2010; Song et al., 2014). Therefore,
stem cell function is correlated both with energy metabolism
and ROS levels, but the molecular mechanisms behind this
interaction are not clear (Perales-Clemente et al., 2014; Teslaa
and Teitell, 2015).
At the core of maintaining pluripotency is the octamer-binding
transcription factor 4 (OCT4), which is essential for the formation
of the inner cell mass of the blastocyst (Nichols et al., 1998) and
the generation of iPSCs (Yu et al., 2007). OCT4 is encoded by
the POU5F1 gene, a member of the POU family of transcription
factors that consists of two DNA binding domains capable of
independently recognizing half-sites of an octameric DNA
sequence motif. OCT4 binds to more than 600 promoters, usu-
ally together with SOX2 and NANOG, and can induce gene
expression related to pluripotency as well as silence genes
involved in differentiation (Boyer et al., 2005). Depletion of
OCT4 leads to spontaneous differentiation (Hay et al., 2004;
Matin et al., 2004; Niwa et al., 2000), and regulation of OCT4
by growth factor signaling has been well described (Rizzino,
2013; Xu et al., 2005).
We demonstrate here that glutamine metabolism is a crucial
regulator of pluripotency in hESCs because it directly regulates
OCT4 oxidation and degradation. Glutamine is taken up avidly in
hESCs (as shown by stable-isotope-assisted metabolomic anal-
ysis), and glutamine metabolism is downregulated upon differ-
entiation. Glutamine is required for maintaining high levels of
the intracellular antioxidant glutathione (GSH), and glutamine
depletion leads to increased ROS levels, resulting in OCT4
cysteine oxidation. Oxidation of OCT4 leads to its rapid degra-
dation, and cysteines 185, 198, 221, and 252 were shown by
site-directed mutagenesis to be essential for DNA binding of
OCT4. Lowering OCT4 levels significantly enhanced endothelial
differentiation and increased endothelial cell sprouting and
neovascularization in vivo. Our findings therefore demonstrate
that the metabolic pathways that are modulated during differen-
tiation directly regulate OCT4, reinforcing and stabilizing theCell Reports 16, 323–332, July 12, 2016 ª 2016 The Author(s). 323
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process of differentiation via a metabolism-differentiation feed-
back loop.
RESULTS
OCT4 Protein Levels Are Regulated by Glutamine
Metabolism
As cytosolic glycolysis leads to lactate production and secre-
tion, other carbon sources are necessary to synthesize lipids
and amino acids in a process referred to as anaplerosis
(DeBerardinis et al., 2008). Glutamine is the highest consumed
amino acid in hESCs (Christensen et al., 2014) and it improves
the generation of embryos after in vitro fertilization (Devreker
et al., 1998). Moreover, the expression of SLC1A5 and GLS2,
respectively the major glutamine uptake transporter and mito-
chondrial glutaminase involved in converting glutamine into
glutamate (Hensley et al., 2013), decreases during spontaneous
differentiation (Figure S1A). Therefore, we decided to investi-
gate the relationship between glutamine metabolism and plurip-
otency. Interestingly, glutamine withdrawal by itself led to a
marked downregulation of OCT4 protein expression in hESCs
(Figures 1A and 1B). In contrast to OCT4, the protein levels of
the pluripotency regulator NANOG were not influenced by
glutamine withdrawal (Figure S1B). We confirmed the functional
significance of decreased OCT4 protein expression by showing
lower OCT4 DNA binding activity (Figure 1C). Supplying alpha-
ketoglutarate (a-KG), an intracellular metabolite of glutamine,
rescued OCT4 DNA binding activity in glutamine-depleted
hESCs. This suggested that the anaplerotic uptake of gluta-
mine-derived carbon atoms into the tricarboxylic acid (TCA)
cycle or the generation of other a-KG-derived metabolites
was crucial for maintaining OCT4 levels. The downregulation
of OCT4 could be due to the decreased expression of OCT4
in hESC subsets, or OCT4hi cells may selectively undergo cell
death. We therefore performed intracellular flow cytometric
analysis of OCT4 and cleaved PARP, a reliable marker of
apoptosis (Figure S1C). We observed the appearance of an
OCT4lo population as soon as 1 day after glutamine withdrawal,
but importantly, there was no significant increase in apoptosis
with glutamine withdrawal (Figure 1D), and we also did not
observe any significant difference in cell death between OCT4lo
and OCT4hi cells. This indicates that the glutamine withdrawal-
induced decrease of OCT4 is driven by the appearance of an
OCT4lo cell population and not due to selective cell death.
The reduction in OCT4 protein was also not due to changes
in OCT4 mRNA levels (Figure S1D) but rather a consequence
of accelerated OCT4 protein degradation (Figures 1E and
S1E). In contrast, NANOG half-life was not altered by glutamine
withdrawal (Figure S1F). During spontaneous differentiation,
OCT4 levels decreased only slightly after 4 days whereas gluta-
mine withdrawal significantly accelerated OCT4 degradation
during spontaneous differentiation, and the magnitude of the
glutamine effect on OCT4 downregulation was more profound
than that of spontaneous differentiation alone (Figure S2A).
We also determined whether the observed OCT4 loss was
due to an overall decrease in the energy state of the cells. We
found that in the absence of glutamine, hESCs were able to
use glucose to maintain their ATP levels, thus indicating that324 Cell Reports 16, 323–332, July 12, 2016the glutamine regulation of OCT4 levels was not secondary to
a drop in ATP levels (Figure S2B).
Glutamine-Derived GSH Is Required to Keep ROS Levels
Low in hESCs, whereas Increased ROS Leads to a Rapid
Downregulation of OCT4
Because glutamine is a precursor of glutamate, a building block
of the cellular antioxidant GSH (Sies, 1999), we next investi-
gated whether OCT4 is oxidized after glutamine withdrawal.
Levels of GSH were markedly lower after glutamine withdrawal
(Figure 2A) and resulted in the oxidation of GSH to glutathione
disulfide (GSSG; Figure 2A). We also used the mitochondrial
superoxide-specific probe MitoSOX and found increased
ROS levels in the absence of glutamine, confirming a more
oxidized cellular environment (Figure 2B). To prove that a shift
toward an oxidized redox state in the ESCs mediated the
observed loss of OCT4, we cultured ESCs in presence of
cell-permeable GSH. The addition of GSH rescued OCT4
degradation induced by glutamine withdrawal (Figure 2C), con-
firming the importance of GSH in maintaining cellular OCT4
levels. Finally, to demonstrate that increased ROS by itself
can lead to reduced OCT4 activity, we incubated hESCs with
DMNQ, a cell-permeable redox cycling quinone that leads to
intracellular superoxide formation. We observed a dose-depen-
dent decrease in OCT4 DNA binding within 5 hr (Figures 2D and
S2C) and a reduction of OCT4 protein levels (Figures 2E and
2F), clearly demonstrating that oxidation can lead to a rapid
degradation of OCT4.
Cysteines Play a Crucial Role in DNA Binding of OCT4
and Are Oxidized after Glutamine Withdrawal
Cysteines are especially vulnerable to oxidative modifications
(Cremers and Jakob, 2013), and regulation of transcription fac-
tor DNA binding activity by cysteine oxidation has been
described for several transcription factors, including p53,
AP-1, and NF-kB (Abate et al., 1990; Hainaut and Milner,
1993; Matthews et al., 1992; Rainwater et al., 1995; Sun and
Oberley, 1996). To investigate whether cysteine oxidation of
OCT4 is a regulatory target of glutamine metabolism, we incu-
bated protein lysates with maleimide-biotin to label reduced
cysteine groups. Pull-down of biotin-labeled proteins followed
by an immunoblot for OCT4 shows that OCT4 cysteines were
oxidized after 2 days of glutamine withdrawal (Figure 3A). We
observed a similar pattern of OCT4 oxidation during sponta-
neous differentiation in the absence of glutamine (Figure S2D).
Of the nine cysteines in OCT4, four are found in the N-terminal
domain, while the DNA binding POUs and POUh domains each
contain two cysteines. One final cysteine is present in the linker
region between both DNA binding domains (Figure 3B). Since it
is unknown which cysteines regulate OCT4 transcriptional ac-
tivity, we first performed an alignment of OCT4 proteins from
different mammal species. Importantly, all nine cysteines are
conserved across species, further underscoring the importance
of redox-sensitive cysteines as a conserved regulatory mecha-
nism (Figure 3C). The reactivity of cysteines is enhanced by
positively charged amino acids in their vicinity (Britto et al.,
2002), and several cysteines contain either arginine or lysine
immediately adjacent to them (Figure 3C). We then performed
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Figure 1. Glutamine Regulates OCT4 Expression in hESCs
(A) Immunofluorescent staining for OCT4 in hESCs cultured with or without glutamine for 4 days showed marked decreases in the protein level of OCT4 in
response to glutamine withdrawal. Images were obtained at the same magnification. Scale bar, 20 mm. n = 48–50 cells per group.
(B) Immunoblot showing downregulation of OCT4 in hESCs cultured in the absence of glutamine for 4 days.
(C)OCT4DNAbindingactivity to itscanonicalDNAsequence isdecreasedafter 2daysofglutaminewithdrawal, indicating reducedOCT4activity.Alpha-ketoglutarate
(a-KG) restored normal OCT4 DNA binding, showing that the reduction in OCT4 activity is not a non-specific response to glutamine withdrawal. n = 4 per group.
(D) Flow cytometry for OCT4 and cleaved PARP, a marker of apoptosis. Results show that a group of OCT4lo cells is present after just 1 day of glutamine
withdrawal. At the same time, OCT4hi cells are not apoptotic, indicating that selective death of OCT4 high cells is not an explanation for the observed overall OCT4
downregulation. n = 8 per group.
(E) Protein degradation was assessed using the protein synthesis inhibitor cycloheximide (CHX). In medium with glutamine, OCT4 protein levels were stable after
8 hr of CHX treatment, indicating a protein half-life of greater than 8 hr. Glutamine withdrawal for 2 days lowered the baseline OCT4 protein level and enhanced its
degradation, leading to a protein half-life of 8 hr. For a time course of OCT4 protein levels after CHX treatment, please see Figure S1E.
*p < 0.05, **p < 0.01, ***p < 0.001 (unpaired Student’s t test for comparison between two groups and ANOVA with post hoc Tukey’s test for multiple group
comparisons). Error bars show SEM.
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Figure 2. Glutamine Withdrawal Decreases Antioxidant Defenses and Leads to OCT4 Oxidation and Inactivation
(A) Glutamine withdrawal for 2 days decreased intracellular glutathione (GSH) levels and decreased the ratio of reduced glutathione versus oxidized glutathione
disulfide (GSSG). n = 4 per group.
(B) Glutamine withdrawal for 2 days increased mitochondrial superoxide levels as measured by MitoSOX fluorescence. MitoTracker green signal intensity is not
different between both groups, indicating equal total mitochondrial content. n = 3 per group.
(C) Supplying cell-permeable glutathione prevents degradation of OCT4 induced by glutamine withdrawal.
(D) OCT4 activity decreases in response to reactive oxygen species in cells treated for 5 hr with the intracellular superoxide generator DMNQ. n = 4 per group.
(E) Treatment for 5 hr with 100 mM DMNQ led to decreased OCT4 intensity in hESCs. Scale bar, 20 mm.
(F) Total OCT4 protein levels decrease after incubation with 100 mM DMNQ for 5 hr, indicating that oxidation leads to the rapid degradation of OCT4. n = 4 per
group.
*p < 0.05, **p < 0.01, ***p < 0.001 (unpaired Student’s t test for comparison between two groups and ANOVA with post hoc Dunnett’s test for multiple group
comparisons). Error bars show SEM.separate site-directed mutagenesis to convert each of the nine
cysteines present in OCT4 to glycine (Figure S2E). Transfection
led to a uniform overexpression of OCT4 (Figure 3D). However,
in vitro DNA binding activity was decreased when cysteines
185, 198 (in the POUs domain), 221 (in the linker region), and
252 (in the POUh domain) were mutated (Figure 3E), and all
of these cysteines contain a positively charged amino acid in
their vicinity (Figure 3C).326 Cell Reports 16, 323–332, July 12, 2016Glutamine Withdrawal and OCT4 Degradation Promote
Endothelial Differentiation and Angiogenesis
Downregulation of the pluripotency factor OCT4 secondary to a
shift away from glutamine metabolism could serve as metabolic
cue toward a differentiated state. To specifically evaluate the in-
fluence of OCT4 downregulation, we generated stable hESC cell
lines expressing doxycycline-inducible small hairpin RNA
(shRNA) against OCT4 (for validation, see Figure S3A). We then
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Figure 3. Cysteines 185, 198, 221, and 252 Are Required for DNA Binding of OCT4
(A) Protein lysates of hESCs were incubated with maleimide-biotin to label reduced cysteine groups. Pull-down of biotin-labeled proteins is followed by an
immunoblot for OCT4. For each sample, total nuclear extract (input) and pulled down (PD) or reduced OCT4 are shown side by side. The percentage of reduced
OCT4 is calculated aftermeasuring the relative band intensities. Glutaminewithdrawal for 2 days leads to amarked reduction in reduced cysteines as significantly
less OCT4 is pulled down. n = 5 per group.
(B) Schematic representation of OCT4 with cysteine amino acids indicated. In total, there are nine cysteines in OCT4: four in the N-terminal domain (NTD), two in
the POUs DNA binding domain, one in the linker, and two in the POUh DNA binding domain. There are no cysteines in the C-terminal domain (CTD).
(C) Sequence alignment of OCT4 from different mammals reveals that all nine cysteines of OCT4 are conserved across species. Since the reactivity of cysteines is
enhanced by positively charged amino acids like arginine (R) and lysine (K), we indicated those amino acids with a ‘‘+’’ sign.
(D) HumanOCT4 cDNA was cloned into the pEGFP vector, and site-directed mutagenesis was then used to separately mutate each of the cysteines into glycine.
Immunoblotting confirmed a robust overexpression of OCT4 for each of the mutations in HEK293T cells.
(E) OCT4 activity in nuclear isolates was assessed after transfection. Mutation of cysteines 185, 198, 221, and 252 each led to a significant reduction in DNA
binding. The average empty vector measurement was subtracted from all samplemeasurements, and the resulting value was normalized to the OCT4 expression
level of each sample. n = 4–6 per group.
*p < 0.05, **p < 0.01, ***p < 0.001 (unpaired Student’s t test for comparison between two groups and ANOVA with post hoc Dunnett’s test for multiple group
comparisons). Error bars show SEM.cultured cells for different days in the presence of doxycycline
and assessed expression of the transcription factorsOTX2 (early
ectodermal marker) (Zakin et al., 2000) and SOX17 (early mesen-
dodermal marker) (Choi et al., 2012) as early indicators of differ-entiation. While ectodermal differentiation was not enhanced by
the induced downregulation OCT4, we observed a clear increase
in SOX17 expression (Figure S3B), thus suggesting that loss of
OCT4 guides ESCs toward a mesendodermal lineage. To furtherCell Reports 16, 323–332, July 12, 2016 327
evaluate mesendodermal differentiation, we investigated the
expression ofGATA2, a zinc-finger transcription factor that is ex-
pressed during early differentiation of mesendodermal progeni-
tors toward an endothelial lineage (Lugus et al., 2007). OCT4
downregulation resulted in marked increase of GATA2 (Fig-
ure 4A). Importantly, the order of magnitude of OCT4 reduction
induced by individual shRNA clones after 4 days of induction
(Figure 4A) was similar to that seen by glutamine withdrawal (Fig-
ure 1B), thus demonstrating that glutamine withdrawal results in
functional decreases of OCT4 that can induceGATA2. Based on
these findings, we hypothesized that endothelial differentiation
of hESCs would be markedly enhanced following downregula-
tion of glutamine metabolism and the resultant decrease in
OCT4 activity.
We developed an endothelial differentiation protocol consist-
ing of 4 days of differentiation in the presence of vascular endo-
thelial growth factor (VEGF) and bone morphogenetic protein 4
(BMP4), which generates functional vascular endothelial cells
with a typical cobblestone morphology and the ability to form
vascular networks on Matrigel (Figure S3C). Moreover, cells uni-
formly expressed the endothelial markers VEGFR2, CD31, and
VE-cadherin (Figure S3D).
We first assessed the potential regulatory role of glutamine
metabolism in endothelial differentiation by performing a stable
isotopic study using [13C5]-labeled glutamine coupled with ame-
tabolomic analysis. We found that ESC-derived endothelial cells
demonstrate significantly lower entry of glutamine-derived
metabolites into the TCA cycle, consistent with the idea that
glutamine metabolism is downregulated during endothelial
differentiation (Figure S4). This suggested that glutamine with-
drawal could be used to enhance endothelial lineage commit-
ment. Complete glutamine deprivation prevented successful
endothelial formation, likely due to the fact that OCT4 activity
is initially required to upregulate Brachyury, a transcription factor
required for mesodermal differentiation (Karwacki-Neisius et al.,
2013; Radzisheuskaya et al., 2013; Wang et al., 2012). However,
targeted glutamine withdrawal during the second half of the
4-day differentiation protocol, once differentiating cells are
committed to the mesodermal lineage, markedly increased the
hematopoietic and endothelial marker CD34 (Figures 4B and
4C). The number of cells expressing the endothelial cell-adhe-
sion molecule CD31, a marker of endothelial maturation, also
increased after targeted glutamine withdrawal (Figure 4D). To
investigate the functional capacity of ESC-derived endothelial
cells obtained under glutamine withdrawal, we used a
collagen-based in vitro three-dimensional sprouting assay. We
observed a significant enhancement of vessel sprouting in
ESC-derived cells obtained under glutamine withdrawal (Fig-
ure 4E). This indicated that by suppressing glutamine meta-
bolism during ESC differentiation, endothelial cells not only
increased in number but also exhibited an increased capacity
to form functional blood vessels. Importantly, we implanted
hESC-derived endothelial cells into Matrigel plugs in immune-
deficient non-obese diabetic severe combined immunodefi-
ciency (NOD-SCID) mice for 7 days to engineer human blood
vessels in vivo.We found that hESCs differentiated with selective
glutamine withdrawal demonstrated a 4-fold-higher number of
red blood cells in the newly formed blood vessels. This indicated328 Cell Reports 16, 323–332, July 12, 2016that glutamine withdrawal during ESC differentiation increased
the function of the engineered human blood vessels (Figure 4F).
DISCUSSION
We describe here an important mechanism by which glutamine
metabolism regulates hESC pluripotency via redox-dependent
oxidation and degradation of the transcription factor OCT4.
We observed that genes involved in glutamine uptake and
metabolism are highly expressed in undifferentiated hESCs
compared to spontaneously differentiated cells. We also
observed that glutamine is converted more efficiently into gluta-
mate and leads to greater labeling of citrate when compared to
differentiated endothelial cells. Other than fueling the TCA cycle,
glutamine is also essential for maintaining cellular GSH levels.
We observed that transient glutamine withdrawal increased
ROS formation, cysteine oxidation of OCT4, and its degradation.
Moreover, oxidation-dependent degradation of OCT4 induced
by glutamine withdrawal is shown to enhance endothelial differ-
entiation and in vivo blood vessel formation.
A major finding in our study is that glutamine, by maintaining a
reduced redox state, regulates OCT4 levels. OCT4 is encoded
by the POU5F1 gen and is a member of the POU family of tran-
scription factors that consists of two DNA binding domains
capable of independently recognizing half-sites of an octameric
DNA sequence motif. OCT4 is essential both for the formation of
the inner cell mass of the blastocyst (Nichols et al., 1998) and
generation of iPSCs (Yu et al., 2007). The POU5F1 gene encodes
for three different splice variants, but pluripotency depends only
on the OCT4A isoform (Lee et al., 2006). OCT4 binds to more
than 600 promoters, usually together with SOX2 and NANOG,
and can both induce gene expression related to pluripotency
and silence genes involved in differentiation (Boyer et al.,
2005). Work in mouse ESCs and iPSCs has shown that pluripo-
tency can be maintained with low levels of OCT4, and cells ex-
pressing low levels of OCT4 prior to differentiation are in a state
of enhanced stability and less likely to undergo subsequent dif-
ferentiation (Karwacki-Neisius et al., 2013; Radzisheuskaya
et al., 2013). In contrast, OCT4 depletion in hESCs leads to spon-
taneous endodermal (Hay et al., 2004) and trophectodermal dif-
ferentiation (Matin et al., 2004). We observed that glutamine
removal generates an OCT4lo population (Figure 1D), and it has
been previously reported that OCT4lo cells fail to upregulate
the mesodermal marker Brachyury in response to BMP4
(Wang et al., 2012), which is a prerequisite for endothelial differ-
entiation. This emphasizes the importance of timing a metabolic
intervention during the differentiation process. Indeed, glutamine
withdrawal from the onset of differentiation inhibited endothelial
formation, whereas lowering OCT4 after differentiation has been
initiated may enhance differentiation.
ESCs maintain low levels of ROS (Cho et al., 2006) and have a
high expression of antioxidant proteins (Saretzki et al., 2008).
Moreover ROS enhance and in some cases are essential for
the differentiation of ESCs into different lineages (Crespo et al.,
2010; Ji et al., 2010; Lin et al., 2012). This suggests that ROS
levels and stem cell pluripotency are correlated, yet the mecha-
nisms underlying themetabolic regulation of pluripotency and its
functional importance for enhancing differentiation have not yet
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Figure 4. Enhanced Endothelial Differentiation and Angiogenesis in Response to Glutamine Withdrawal
(A) Stable hESC cell lines that express doxycycline-inducible shRNA againstOCT4were cultured in the presence of doxycycline for different days. Knockdown of
OCT4 increases the zinc-finger transcription factor GATA2, which is involved in early hemangioblast differentiation from mesodermal precursors, suggesting a
mechanism by which OCT4 downregulation could lead to enhanced endothelial cell formation. Matching immunoblots are shown to indicate the residual level of
OCT4 protein over time. Triplicate mRNA measurements were done for each clone at each time point.
(B) Glutamine withdrawal during the final 2 days of a 4-day endothelial differentiation protocol increases the percentage of CD34+ cells as shown by flow cy-
tometry. n = 6 per group.
(C) Immunoblot confirming the upregulation of CD34, indicative of a shift toward the endothelial cell lineage. n = 4 per group.
(D) Quantification of CD31+ cells after endothelial differentiation of hESCs. Cells either received glutamine for the entire 4 days of differentiation or were
differentiated in the absence of glutamine for the final 2 days. After differentiation, cells were subcultured onto collagen-coated coverslips and stained the next
day for CD31. Quantification reveals a significant increase in the percentage of CD31+ cells. n = 10 high-power fields per condition. Scale bar, 20 mm.
(E) In vitro sprouting angiogenesis assay on collagen gels. hESCs were first differentiated for 4 days, and 50,000 cells were then plated on top of the collagen gel.
After 72 hr, cells were fixed with 3% glutaraldehyde in PBS, and invading sprouts were counted after staining with 0.1% toluidine blue in 30%methanol. Images
were focused below the surface monolayer to visualize invading sprouts (white arrows). Sprouts were quantified by counting the number of sprouts per high-
power field (n = 9 high-power fields belonging to three different gels per group). Scale bar, 100 mm.
(F) hESCs were either differentiated toward endothelial cells for 4 days (+Gln group) or exposed to glutamine withdrawal during the final 2 days of differentiation
(Gln group). Equal numbers of cells were then mixed with Matrigel and implanted subcutaneously for 7 days. We observed increased formation of functional
perfused blood vessels, measured by the number of red blood cells per high-power field (RBC/HPF), in plugs with cells differentiated in the absence of glutamine
(three plugs per group with 10 high-power fields per plug). Scale bar, 50 mm.
*p < 0.05, **p < 0.01, ***p < 0.001 (unpaired Student’s t test for comparison between two groups in B, D, and E and ANOVAwith post hoc Dunnett’s test formultiple
group comparisons in A). Because data in (F) were not normally distributed (Kolmogorov-Smirnov test), aMann-Whitney test was used to compare red blood cells
per high-power field. Error bars show SEM.
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been understood (Perales-Clemente et al., 2014; Teslaa and Tei-
tell, 2015). Our findings directly demonstrate that glutamine
metabolism maintains the reduced redox state and that gluta-
mine withdrawal leads to a rapid degradation of OCT4, thus es-
tablishing a direct relationship between glutamine metabolism
and pluripotency regulation.
Chemical oxidation of OCT4 in a cell-free system has been
shown to lower its in vitro DNA binding capacity (Guo et al.,
2004), but our data demonstrate that OCT4 acts as a metabolic
sensor for glutamine metabolism in hESCs and can respond to
metabolic cues as potent drivers of stem cell differentiation.
We observed an almost complete oxidation of OCT4 cysteines
after glutamine withdrawal. Oxidation or modification of cyste-
ines can similarly inactivate other transcription factors, such as
p53, AP-1, and NF-kB. For example, the DNA binding domain
of p53 contains several cysteines that were shown by X-ray crys-
tallography to electrostatically interact with a zinc atom (Cho
et al., 1994). Oxidation of thiols with diamide reduced DNA bind-
ing of p53 (Hainaut and Milner, 1993), and site-directed muta-
genesis of cysteines in the DNA binding domain of p53 led to a
complete loss of DNA binding activity (Rainwater et al., 1995).
Similarly, cFos-cJun heterodimers were unable to bind to DNA
once free thiols weremodified with N-ethylmaleimide, andmuta-
genesis identified a single cysteine residue that was necessary
for DNA binding (Abate et al., 1990). Also, NF-kB activity is in-
hibited by sulfhydryl modifying agents, and a single cysteine
was shown to be necessary for DNA binding (Matthews et al.,
1992). In addition, several other transcription factors have been
shown to be impaired by cysteine oxidation (Sun and Oberley,
1996).
Our findings also complement a recent study that identified
the role of glutamine metabolism as a regulator of epigenetic
DNA methylation in murine ESCs (Carey et al., 2015), thus
suggesting that glutamine can modulate gene expression via
transcriptional as well as epigenetic mechanisms in ESCs. Our
findings point to a rapid inactivation of OCT4 DNA binding in
response to ROS generated by glutamine withdrawal. We also
observed that during differentiation, ESCs downregulate gluta-
mine metabolism, which thus suggests an important feedback
mechanism between the metabolic state of an ESC and its plu-
ripotency. Differentiation downregulates glutamine metabolism,
which in turn enhances differentiation by oxidizing the transcrip-
tion factor OCT4. This feedback mechanism can allow pluripo-
tent stem cells to rapidly achieve a stable differentiated fate. It
is also conceivable that the rapid direct inactivation of OCT4
andmore permanent epigenetic modification of gene expression
reinforce each other, highlighting the versatile roles of glutamine
metabolism in regulating pluripotency and differentiation. Impor-
tantly, transient glutamine withdrawal during differentiation
enables hESCs to significantly increase the generation of endo-
thelial cells that can form functional blood vessels, thus under-
scoring the role of metabolic shifts for enhancing the functional
capacity of generated cells.
The importance of energy metabolism is further highlighted by
a recent publication showing that glucose deprivation can be
used to select for differentiated cardiomyocytes, as these cells
can typically use lactate to fuel the TCA cycle and can survive
in the absence of glucose (Tohyama et al., 2013). Differentiation330 Cell Reports 16, 323–332, July 12, 2016protocols often rely on growth factors or extracellular matrices to
induce differentiation, but our findings demonstrate that the
metabolic milieu may be a similarly important factor in differenti-
ating stem cells.
Our finding that the engineering of functional blood vessels
from hESCs is improved by metabolic modulation is especially
important for translational applications to enhance angiogenesis
with hESC-derived endothelial cells in situ and generate de novo
blood vessels for tissue engineering. Our study focused on the
role of glutamine metabolism in the generation of endothelial
cells, but since OCT4 is a key regulator of pluripotency, it is likely
that the regulatory role of glutamine metabolism also applies to
the generation of other mature cell types and tissues during
development and for regenerative tissue engineering. Future
studies on the role of targeted metabolic interventions during
the differentiation of pluripotent stem cells will help us under-
stand and harness the complex interactions between the meta-
bolic milieu and stem cell fate.
EXPERIMENTAL PROCEDURES
Additional experimental methods can be found in Supplemental Experimental
Procedures.
hESC Culture and Differentiation
H1 hESCs (WiCell) were cultured with conditioned medium containing fresh
10 ng/ml basic fibroblast growth factor (bFGF; R&D Systems) and 100 ng/ml
heparin (Sigma-Aldrich). For spontaneous differentiation, medium was not
conditioned, and bFGF and heparin were left out. Endothelial differentiation
was started by adding 20 ng/ml bFGF, 25 ng/ml BMP4, and 50 ng/ml VEGF
(all from R&D Systems). To measure the effect of glutamine withdrawal on
endothelial differentiation, glutamine was removed from the medium for the
final 2 days of a 4-day differentiation.
OCT4 Transcription Factor Assay and Oxidation of OCT4
Nuclear extracts were incubated overnight in wells coated with double-
stranded DNA containing the OCT4 response element, and OCT4 binding
was quantified according to the manufacturer’s instructions (Cayman Chemi-
cal). To induce intracellular superoxide formation, cells were treated for 5 hr
with different concentrations of 2,3-dimethoxy-1,4-naphthoquinone (DMNQ;
Sigma-Aldrich). OCT4 oxidation status was determined by incubating cells
on ice for 4 hr with EZ-Link Maleimide-PEG2-Biotin (Thermo Fisher Scientific)
to label reduced thiols.
GSH/GSSG Measurements
Cells were first cultured in the presence or absence of glutamine for 2 days and
then oxidized, and reduced glutathione levels were measured using the GSH/
GSSG-Glo Assay kit (Promega). Cell-permeable GSH (glutathione reduced
ethyl ester) was obtained from Sigma-Aldrich and used at 0.5 mM.
Endothelial Sprouting Assay
Invasion into 3D collagen gels was quantified using previously published
methods (Bayless et al., 2009; Kang et al., 2015) using rat tail collagen type I
containing 200 ng/ml VEGF (R&D Systems). hESCs were differentiated toward
endothelial cells for a total of 4 days, and the glutamine withdrawal group did
not receive glutamine during the final 2 days of differentiation. 50,000 cells
were plated on top of the collagen gels in fresh endothelial basal medium
(Lonza). After 72 hr, endothelial sprouting was quantified as the number of
structures invading beneath the monolayer per high-power field.
Mouse Experiments
Animal experiments were performed according to National Institutes of
Health (NIH) guidelines for the care and use of live animals and were approved
by our institutional animal care and use committee. 10-week-old male
NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice (strain 005557, The Jackson Labora-
tory) were injected with 4 million cells in 250 ml growth factor reduced Matrigel
(Corning). After 7 days, the number of red blood cells per high-power field was
determined.
Statistics
All values are given asmean ± SEM. Inter-group differences were assessed by
an unpaired Student’s t test or an ANOVAwith post hoc analysis using Tukey’s
test when multiple groups were analyzed. Wherever applicable, normality was
confirmed with the Kolmogorov-Smirnov test, and for data that were not nor-
mally distributed (red blood cells per high-power field in Figure 4F), a Mann
Whitney test was used. p < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.05.089.
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